BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16484092)

  • 1. Validity and stability of performance-based estimates of premorbid educational functioning in older patients with schizophrenia.
    Harvey PD; Friedman JI; Bowie C; Reichenberg A; McGurk SR; Parrella M; White L; Davis KL
    J Clin Exp Neuropsychol; 2006 Feb; 28(2):178-92. PubMed ID: 16484092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premorbid adjustment in first episode schizophrenia and schizoaffective disorders: a comparison of social and academic domains.
    Norman RM; Malla AK; Manchanda R; Townsend L
    Acta Psychiatr Scand; 2005 Jul; 112(1):30-9. PubMed ID: 15952943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of word-reading to estimate "premorbid" ability in cognitive domains other than intelligence.
    Schretlen DJ; Buffington AL; Meyer SM; Pearlson GD
    J Int Neuropsychol Soc; 2005 Oct; 11(6):784-7. PubMed ID: 16248914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome.
    Keefe RS; Poe M; Walker TM; Harvey PD
    J Clin Exp Neuropsychol; 2006 Feb; 28(2):260-9. PubMed ID: 16484097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 1993 Jan; 18(1):18-23. PubMed ID: 8461276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining a cognitive function decrement in schizophrenia.
    Keefe RS; Eesley CE; Poe MP
    Biol Psychiatry; 2005 Mar; 57(6):688-91. PubMed ID: 15780858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in neuropsychological functioning among schizophrenia patients.
    Bozikas VP; Kosmidis MH; Peltekis A; Giannakou M; Nimatoudis I; Karavatos A; Fokas K; Garyfallos G
    Aust N Z J Psychiatry; 2010 Apr; 44(4):333-41. PubMed ID: 20050721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: a prospective three-year follow-up study.
    Chang WC; Tang JY; Hui CL; Wong GH; Chan SK; Lee EH; Chen EY
    Psychiatry Res; 2013 Oct; 209(3):353-60. PubMed ID: 23473654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proposed method to estimate premorbid intelligence utilizing group achievement measures from school records.
    Baade LE; Schoenberg MR
    Arch Clin Neuropsychol; 2004 Mar; 19(2):227-43. PubMed ID: 15010088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between cognitive defects and the course of schizophrenia. Initial study of a rehabilitation programme participants].
    Hanuszkiewicz I; Cechnicki A; Kalisz A
    Psychiatr Pol; 2007; 41(4):539-50. PubMed ID: 18046984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Social outcome of schizophrenics in Tunisia: a transversal study of 60 patients].
    Rafrafi R; Zaghdoudi L; Mahbouli M; Bouzid R; Labbane R; El Hechmi Z
    Encephale; 2009 Jun; 35(3):234-40. PubMed ID: 19540409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive development in schizophrenia: follow-back from the first episode.
    Bilder RM; Reiter G; Bates J; Lencz T; Szeszko P; Goldman RS; Robinson D; Lieberman JA; Kane JM
    J Clin Exp Neuropsychol; 2006 Feb; 28(2):270-82. PubMed ID: 16484098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of medication competence in schizophrenia patients.
    Heinrichs RW; Goldberg JO; Miles AA; McDermid Vaz S
    Psychiatry Res; 2008 Jan; 157(1-3):47-52. PubMed ID: 17897721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimensions of premorbid functioning in schizophrenia: a review of neuromotor, cognitive, social, and behavioral domains.
    Schenkel LS; Silverstein SM
    Genet Soc Gen Psychol Monogr; 2004 Aug; 130(3):241-70. PubMed ID: 15819307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Learning potential and cognitive remediation in schizophrenia].
    Raffard S; Gely-Nargeot MC; Capdevielle D; Bayard S; Boulenger JP
    Encephale; 2009 Sep; 35(4):353-60. PubMed ID: 19748372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of premorbid functioning in first episode psychosis: relationship to 2-year outcome.
    Addington J; Addington D
    Acta Psychiatr Scand; 2005 Jul; 112(1):40-6. PubMed ID: 15952944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.
    Harvey PD; Serper MR; White L; Parrella MJ; McGurk SR; Moriarty PJ; Bowie C; Vadhan N; Friedman J; Davis KL
    Compr Psychiatry; 2001; 42(4):306-13. PubMed ID: 11458305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients.
    Bowie CR; Serper MR; Riggio S; Harvey PD
    Schizophr Bull; 2005 Jan; 31(1):175-82. PubMed ID: 15888435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.